Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards is a research paper published in Surgical Oncology Clinics of North America (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
NCI NIH HHS
Grant: U10 CA180888
NCI NIH HHS
Grant: UG1 CA233198
National Cancer Institute
National Institutes of Health
Boehringer Ingelheim
FWCI
1.56
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords